NIH's top vaccine director retires, adding to the exodus of government vaccine expertise
After more than 20 years of working at NIH, John Mascola, director of NIAID’s vaccine research center and lead on vaccines for Operation Warp Speed, said Wednesday that he will retire at the end of March.
Mascola, who follows the recent departure of NIH director Francis Collins, was at the center of efforts to develop not only Moderna’s legendary Covid-19 vaccine, which has now been administered in millions of people, but also monoclonal antibodies used to treat Covid-19.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.